Benefits and risks of thrombolytic, anticoagulant and antiplatelet therapies in atrial fibrillation
Marchant, B.G.; Timmis, A.D.
British Journal of Hospital Medicine 49(3): 186-190
1993
ISSN/ISBN: 0007-1064 PMID: 8439785 Document Number: 417780
The decision whether to anticoagulate is a common dilemma when faced with a patient with atrial fibrillation. This article reviews the role of warfarin and antiplatelet agents and recommends a rational approach to the management of this condition.
Document emailed within 1 workday
Related Documents
Ro, K.G.; Anderson, H.V. 1990: Thrombolytic therapy in acute MI. Weighing the risks and benefits Postgraduate Medicine 88(8): 79-80 83-6 89-90 PassimSchaerlig, E. 2010: Echoes of the ESC 2010. Atrial fibrillation, rush on antiplatelet agents, genetics omnipresence Revue medicale suisse 6(270): 2151-2152
Frantz, E. 2000: What anticoagulant therapy should be used for what form of atrial fibrillation? Deutsche Medizinische Wochenschrift 125(Suppl 1): S10-S11
Palareti, G. 1996: Anticoagulant therapy in patients with atrial fibrillation: the experience of the Centers of Surveillance. Study group of the "Italian Study on Complications of Oral Anticoagulant Therapy" (ISCOAT) Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 11(Suppl 2): 18s-20s
Lodder, J. 1989: Chronic anticoagulant treatment of patients with non-rheumatic atrial fibrillation Nederlands Tijdschrift Voor Geneeskunde 133(12): 602-603
Matsuda, T. 1993: Antithrombotic drug (thrombolytic drug, anticoagulant, antiplatelet drug) Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 179-185
Wagner, A.D.; Zaman, K.; Peters, S.; Montemurro, M.; Leyvraz, S. 2010: Anti-angiogenic therapies for metastatic colorectal, breast and lung cancer: benefits and risks Revue Medicale Suisse 6(250): 1070-1073
Islam, M.S.; Islam, M.A.; Azad, A.K.; Banerjee, S.K.; Ahmed, C.M.; Haque, H.; Ahmed, M.K.; Rumki, R.S.; Mahmood, M.; Rashid, F.B. 2016: Use of Anticoagulant Warfarin in Patients Presenting with Atrial Fibrillation in a Tertiary Level Hospital Mymensingh Medical Journal: Mmj 25(3): 523-529
Cox, J.L.; Schuessler, R.B.; Boineau, J.P. 1991: The surgical treatment of atrial fibrillation. I. Summary of the current concepts of the mechanisms of atrial flutter and atrial fibrillation Journal of Thoracic and Cardiovascular Surgery 101(3): 402-405
Belenkov, Y.N.; SHakaryants, G.A.; Khabarova, N.V. 2018: Tactics of Selection of Anticoagulant Therapy in Patients With Atrial Fibrillation and Ischemic Heart Disease Kardiologiia 2018(3): 43-52
Strain, J.; Templeton, K. 2013: Is Apixaban (Eliquis) the "ideal" anticoagulant to replace warfarin for stroke prevention in atrial fibrillation? South Dakota Medicine: the Journal of the South Dakota State Medical Association 66(1): 20-21
Setiabudi, E.; Alwi, I.; Setiati, S. 2008: Oral anticoagulant treatment in management of elderly patients with atrial fibrillation [corrected]: is it beneficial or detrimental? Acta Medica Indonesiana 40(1): 40-47
Eskola, K.; Virjo, I.; Isokoski, M.; Aittobiemi, P.; Kurunmäki, H.; Latva-Nevala, A.; Paloneva, M.; Wallin, A.M.; Viitaniemi, M.; Ylinen, S. 1996: Quality of service provision for anticoagulation in atrial fibrillation. In Finland anticoagulant treatment is monitored by general practitioners Bmj 312(7022): 52-53
Fake, A.; Ranchord, A.; Harding, S.; Larsen, P. 2017: Triple Therapy Versus Dual Antiplatelet Therapy for Patients with Atrial Fibrillation and Acute Coronary Syndromes: A Systematic Literature Review Current Cardiology Reviews 13(4): 325-333
Ostroumova, O.D.; Cherniaeva, M.S.; Golovina, O.V. 2018: Atrial fibrillation as Risk Factor for Development of Cognitive Function Impairment and Dementia. Potential of Anticoagulant Therapy in Their Prevention Kardiologiia 58(9): 76-88
Cox, J.L.; Canavan, T.E.; Schuessler, R.B.; Cain, M.E.; Lindsay, B.D.; Stone, C.; Smith, P.K.; Corr, P.B.; Boineau, J.P. 1991: The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation Journal of Thoracic and Cardiovascular Surgery 101(3): 406-426
Ertas, F.; Oylumlu, M.; Akil, M.A.; Acet, H.; Bilik, M.Z.; Celepkolu, T.; Yildiz, A.; Kaya, H.; Alan, S.; Ozhan, H. 2013: Non-valvular atrial fibrillation in the elderly; preliminary results from the National AFTER (Atrial Fibrillation in Turkey: Epidemiologic Registry) Study European Review for Medical and Pharmacological Sciences 17(8): 1012-1016
Wu, G.; Jiang, H.; Huang, C.-x.; Yang, B.; Huang, H.; Wang, Y.-l.; Wang, X.-h.; Liu, H.-f.; Yang, X.-h. 2008: Effects of antiarrhythmic drug use on atrial fibrillation recurrence in atrial fibrillation patients post circumferential pulmonary vein ablation Zhonghua Xin Xue Guan Bing Za Zhi 36(7): 623-626
Lechat, P.; Lardoux, H.; Mallet, A.; Sanchez, P.; Derumeaux, G.; Lecompte, T.; Maillard, L.; Mas, J.L.; Mentré, F.; Pousset, F.; Lacomblez, L.; Pisica, G.; Solbes-Latourette, S.; Raynaud, P.; Chaumet-Riffaud, P. 2000: Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. a randomized trial (FFAACS) Therapie 55(6): 681-689
Wen, S.; Liu, N.; Li, S.; Ning, M.; Kang, J.; Wu, J.; Ruan, Y.; Jiang, C.; Sang, C.; Tang, R.; Long, D.; Yu, R.; Bai, R.; Du, X.; Hu, R.; Dong, J.; Liu, X.; Ma, C. 2015: Predictors of atrial fibrillation recurrence after catheter ablation in hypertrophic cardiomyopathy patients with atrial fibrillation Zhonghua Xin Xue Guan Bing Za Zhi 43(7): 589-594